McLean Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
McLean Asset Management's PFE Position: Q3 2026 in Review
McLean Asset Management reduced its Pfizer (PFE) stake by 0.98% in Q3 2026, selling an estimated $2.18K and leaving 8,324 shares worth $249K. The position accounts for 0.03% of the portfolio, ranked #157.
McLean Asset Management first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $769K in Q4 2021. 2,904 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- McLean Asset Management held 8,324 shares of Pfizer worth $249K as of Q3 2026.
- McLean Asset Management sold 82 Pfizer shares in Q3 2026, an estimated $2.18K.
- Pfizer made up 0.03% of McLean Asset Management's portfolio in Q3 2026, its #157 holding.
- McLean Asset Management first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
- McLean Asset Management's Pfizer position peaked at $769K in Q4 2021.
- 2,904 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on McLean Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.